The representative peptide drugs are glucagon-like peptide-1 (GLP-1) agonists used in the treatment of type 2 diabetes and somatostatin receptor agonists used in the treatment of Cushing’s syndrome [31,32]. The gene discussed is GCG; the disease is Cushing syndrome due to macronodular adrenal hyperplasia.